Literature DB >> 22349807

Aberrant microRNAs expression in CD133⁺/CD326⁺ human lung adenocarcinoma initiating cells from A549.

Sheng Lin1, Jian-Guo Sun, Jing-Bo Wu, Hai-Xia Long, Cong-Hui Zhu, Tong Xiang, Hu Ma, Zhong-Quan Zhao, Quan Yao, An-Mei Zhang, Bo Zhu, Zheng-Tang Chen.   

Abstract

Increasing evidence demonstrates that miRNAs are involved in the dysregulation of tumor initiating cells (TICs) in various tumors. Due to a lack of definitive markers, cell sorting is not an ideal separation method for lung adenocarcinoma initiating cells. In this study, we combined paclitaxel with serum-free medium cultivation (inverse-induction) to enrich TICs from A549 cells, marked by CD133/CD326, defined features of stemness. We next investigated aberrant microRNAs in this subpopulation compared to normal cells with miRNA microarray and found that 50 miRNAs exhibited a greater than 2-fold change in expression. As further validation, 10 miRNAs were chosen to perform quantitative RT-PCR on the A549 cell line and primary samples. The results suggest that aberrant expression of miRNAs such as miR-29ab, miR-183, miR-17-5p and miR-127-3P may play an important role in regulating the bio-behavior of TICs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22349807      PMCID: PMC3887701          DOI: 10.1007/s10059-012-2252-y

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  45 in total

1.  Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.

Authors:  Yohei Shimono; Maider Zabala; Robert W Cho; Neethan Lobo; Piero Dalerba; Dalong Qian; Maximilian Diehn; Huiping Liu; Sarita P Panula; Eric Chiao; Frederick M Dirbas; George Somlo; Renee A Reijo Pera; Kaiqin Lao; Michael F Clarke
Journal:  Cell       Date:  2009-08-07       Impact factor: 41.582

2.  The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs.

Authors:  Ulrich Wellner; Jörg Schubert; Ulrike C Burk; Otto Schmalhofer; Feng Zhu; Annika Sonntag; Bettina Waldvogel; Corinne Vannier; Douglas Darling; Axel zur Hausen; Valerie G Brunton; Jennifer Morton; Owen Sansom; Julia Schüler; Marc P Stemmler; Christoph Herzberger; Ulrich Hopt; Tobias Keck; Simone Brabletz; Thomas Brabletz
Journal:  Nat Cell Biol       Date:  2009-11-22       Impact factor: 28.824

3.  MiR-125b is critical for the suppression of human U251 glioma stem cell proliferation.

Authors:  Lei Shi; Junxia Zhang; Tianhong Pan; Jinfang Zhou; Weiyi Gong; Ning Liu; Zhen Fu; Yongping You
Journal:  Brain Res       Date:  2009-11-27       Impact factor: 3.252

4.  Targeting of integrin beta1 and kinesin 2alpha by microRNA 183.

Authors:  Guorong Li; Coralia Luna; Jianming Qiu; David L Epstein; Pedro Gonzalez
Journal:  J Biol Chem       Date:  2009-11-24       Impact factor: 5.157

5.  Both CD133+ and CD133- subpopulations of A549 and H446 cells contain cancer-initiating cells.

Authors:  Xiangjiao Meng; Ming Li; Xiuwen Wang; Yawei Wang; Daoxin Ma
Journal:  Cancer Sci       Date:  2009-02-20       Impact factor: 6.716

Review 6.  MicroRNA regulation of cancer stem cells and therapeutic implications.

Authors:  Jeffrey T DeSano; Liang Xu
Journal:  AAPS J       Date:  2009-10-20       Impact factor: 4.009

7.  MicroRNA MiR-17 retards tissue growth and represses fibronectin expression.

Authors:  Sze Wan Shan; Daniel Y Lee; Zhaoqun Deng; Tatiana Shatseva; Zina Jeyapalan; William W Du; Yaou Zhang; Jim W Xuan; Siu-Pok Yee; Vinayakumar Siragam; Burton B Yang
Journal:  Nat Cell Biol       Date:  2009-07-26       Impact factor: 28.824

8.  Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.

Authors:  Giulia Bertolini; Luca Roz; Paola Perego; Monica Tortoreto; Enrico Fontanella; Laura Gatti; Graziella Pratesi; Alessandra Fabbri; Francesca Andriani; Stella Tinelli; Elena Roz; Roberto Caserini; Salvatore Lo Vullo; Tiziana Camerini; Luigi Mariani; Domenico Delia; Elisa Calabrò; Ugo Pastorino; Gabriella Sozzi
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-10       Impact factor: 11.205

9.  The role of CD133 in the identification and characterisation of tumour-initiating cells in non-small-cell lung cancer.

Authors:  Virginia Tirino; Rosa Camerlingo; Renato Franco; Donatella Malanga; Antonello La Rocca; Giuseppe Viglietto; Gaetano Rocco; Giuseppe Pirozzi
Journal:  Eur J Cardiothorac Surg       Date:  2009-05-22       Impact factor: 4.191

10.  MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells.

Authors:  Qing Ji; Xinbao Hao; Min Zhang; Wenhua Tang; Meng Yang; Ling Li; Debing Xiang; Jeffrey T Desano; Guido T Bommer; Daiming Fan; Eric R Fearon; Theodore S Lawrence; Liang Xu
Journal:  PLoS One       Date:  2009-08-28       Impact factor: 3.240

View more
  25 in total

1.  MiR-145 regulates cancer stem-like properties and epithelial-to-mesenchymal transition in lung adenocarcinoma-initiating cells.

Authors:  Jingwen Hu; Mantang Qiu; Feng Jiang; Shuai Zhang; Xin Yang; Jie Wang; Lin Xu; Rong Yin
Journal:  Tumour Biol       Date:  2014-06-06

Review 2.  Long Non-coding RNA ZFPM2-AS1: A Novel Biomarker in the Pathogenesis of Human Cancers.

Authors:  Gabriel B K Sasa; Cheng Xuan; Guoliang Lyu; Xianfeng Ding; Fang Meiyu
Journal:  Mol Biotechnol       Date:  2022-01-31       Impact factor: 2.695

3.  MicroRNA-183 promotes migration and invasion of CD133(+)/CD326(+) lung adenocarcinoma initiating cells via PTPN4 inhibition.

Authors:  Conghui Zhu; Xi Deng; Jingbo Wu; Jianwen Zhang; Hongru Yang; Shaozhi Fu; Yan Zhang; Yunwei Han; Yuanmei Zou; Zhengtang Chen; Sheng Lin
Journal:  Tumour Biol       Date:  2016-03-07

4.  miR-873 induces lung adenocarcinoma cell proliferation and migration by targeting SRCIN1.

Authors:  Yushun Gao; Qi Xue; Dali Wang; Minjun Du; Yanjiao Zhang; Shugeng Gao
Journal:  Am J Transl Res       Date:  2015-11-15       Impact factor: 4.060

5.  Serum MicroRNA-4521 is a Potential Biomarker for Focal Cortical Dysplasia with Refractory Epilepsy.

Authors:  Xiaofeng Wang; Yuqiang Sun; Zeshi Tan; Ningwei Che; Anlong Ji; Xiaodong Luo; Xu Sun; Xinyu Li; Kang Yang; Guanyu Wang; Lan Luan; Yaoling Liu; Minghai Wei; Jian Yin
Journal:  Neurochem Res       Date:  2015-12-08       Impact factor: 3.996

6.  Long non-coding RNA GATA6-AS1 upregulates GATA6 to regulate the biological behaviors of lung adenocarcinoma cells.

Authors:  Honggang Kang; Dan Ma; Jing Zhang; Jun Zhao; Mengxiang Yang
Journal:  BMC Pulm Med       Date:  2021-05-15       Impact factor: 3.320

Review 7.  Regulation of miRNAs affects radiobiological response of lung cancer stem cells.

Authors:  Yan-mei Xu; Xing-yun Liao; Xie-wan Chen; De-zhi Li; Jian-guo Sun; Rong-xia Liao
Journal:  Biomed Res Int       Date:  2015-03-01       Impact factor: 3.411

Review 8.  Key nodes of a microRNA network associated with the integrated mesenchymal subtype of high-grade serous ovarian cancer.

Authors:  Yan Sun; Fei Guo; Marina Bagnoli; Feng-Xia Xue; Bao-Cun Sun; Ilya Shmulevich; Delia Mezzanzanica; Ke-Xin Chen; Anil K Sood; Da Yang; Wei Zhang
Journal:  Chin J Cancer       Date:  2015-01

9.  Plasma microRNA panel for minimally invasive detection of breast cancer.

Authors:  Katarina Cuk; Manuela Zucknick; Dharanija Madhavan; Sarah Schott; Michael Golatta; Jörg Heil; Frederik Marmé; Andrey Turchinovich; Peter Sinn; Christof Sohn; Hans Junkermann; Andreas Schneeweiss; Barbara Burwinkel
Journal:  PLoS One       Date:  2013-10-23       Impact factor: 3.240

Review 10.  Noncoding RNAs as novel biomarkers in prostate cancer.

Authors:  C G H Rönnau; G W Verhaegh; M V Luna-Velez; J A Schalken
Journal:  Biomed Res Int       Date:  2014-08-28       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.